![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of RAB8A mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of RAB8A mRNA | CTD | PMID:22206623 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:15099020 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAB8A mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of RAB8A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAB8A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB8A mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | ISO | RGD:621144 | 6480464 | 2, 6-dinitrotoluene affects the expression of RAB8A mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RAB8A mRNA | CTD | PMID:20188158 | 5-fluorouracil | decreases expression | ISO | RGD:1354512 | 6480464 | Fluorouracil results in decreased expression of RAB8A mRNA | CTD | PMID:16709241 | aflatoxin B1 | decreases expression | ISO | RGD:1354512 | 6480464 | Aflatoxin B1 results in decreased expression of RAB8A mRNA | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | RGD:1354512 | 6480464 | Aflatoxin B1 results in increased methylation of RAB8A intron | CTD | PMID:30157460 | aflatoxin B2 | increases methylation | ISO | RGD:1354512 | 6480464 | aflatoxin B2 results in increased methylation of RAB8A intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | RGD:1354512 | 6480464 | Tretinoin results in increased expression of RAB8A mRNA | CTD | PMID:16054129 | ammonium chloride | affects expression | ISO | RGD:621144 | 6480464 | Ammonium Chloride affects the expression of RAB8A mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | ISO | RGD:1354512 | 6480464 | Antirheumatic Agents results in decreased expression of RAB8A mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of RAB8A mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | RGD:1354512 | 6480464 | Benzoapyrene affects the methylation of RAB8A intron | CTD | PMID:30157460 | benzo[e]pyrene | increases methylation | ISO | RGD:1354512 | 6480464 | benzoepyrene results in increased methylation of RAB8A intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:621144 | 6480464 | [INS1 protein co-treated with Diethylhexyl Phthalate] results in decreased expression of RAB8A protein | CTD | PMID:28526321 | bisphenol A | increases expression | ISO | RGD:621144 | 6480464 | bisphenol A results in increased expression of RAB8A mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1354512 | 6480464 | bisphenol A results in decreased expression of RAB8A mRNA | CTD | PMID:29275510 | bisphenol A | decreases expression | ISO | RGD:621144 | 6480464 | bisphenol A results in decreased expression of RAB8A protein | CTD | PMID:28739533 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes, Carbon analog results in increased expression of RAB8A mRNA | CTD | PMID:25554681 | cefixime | increases uptake | EXP | | 6480464 | RAB8A protein results in increased uptake of Cefixime | CTD | PMID:19074526 | cefixime | multiple interactions | EXP | | 6480464 | [RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime | CTD | PMID:19074526 | cisplatin | decreases response to substance | ISO | RGD:1354512 | 6480464 | RAB8A results in decreased susceptibility to Cisplatin | CTD | PMID:21969054 | cisplatin | multiple interactions | ISO | RGD:1354512 | 6480464 | TMEM205 promotes the reaction [RAB8A results in decreased susceptibility to Cisplatin] | CTD | PMID:21969054 | coumestrol | increases expression | ISO | RGD:1354512 | 6480464 | Coumestrol results in increased expression of RAB8A mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | RGD:1354512 | 6480464 | [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of RAB8A mRNA | CTD | PMID:19167446 | curcumin | decreases expression | ISO | RGD:1354512 | 6480464 | Curcumin results in decreased expression of RAB8A mRNA | CTD | PMID:21594647 | cyclosporin A | decreases expression | ISO | RGD:1354512 | 6480464 | Cyclosporine results in decreased expression of RAB8A mRNA | CTD | PMID:20106945 | dicrotophos | increases expression | ISO | RGD:1354512 | 6480464 | dicrotophos results in increased expression of RAB8A mRNA | CTD | PMID:28302478 | doxorubicin | decreases expression | ISO | RGD:1354512 | 6480464 | Doxorubicin results in decreased expression of RAB8A mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | ISO | RGD:1354512 | 6480464 | [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of RAB8A mRNA | CTD | PMID:19167446 | folic acid | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of RAB8A mRNA] | CTD | PMID:22206623 | fonofos | increases methylation | ISO | RGD:1354512 | 6480464 | Fonofos results in increased methylation of RAB8A promoter | CTD | PMID:22847954 | gemcitabine | decreases expression | ISO | RGD:1354512 | 6480464 | gemcitabine results in decreased expression of RAB8A mRNA | CTD | PMID:17039268 | gentamycin | increases expression | ISO | RGD:621144 | 6480464 | Gentamicins results in increased expression of RAB8A mRNA | CTD | PMID:22061828 | haloperidol | decreases expression | ISO | RGD:621144 | 6480464 | Haloperidol results in decreased expression of RAB8A mRNA | CTD | PMID:15860345 | isobutanol | multiple interactions | ISO | RGD:1354512 | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RAB8A mRNA | CTD | PMID:29432896 | lead(0) | affects expression | ISO | RGD:1354512 | 6480464 | Lead affects the expression of RAB8A mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:1354512 | 6480464 | Lead affects the expression of RAB8A mRNA | CTD | PMID:28903495 | methapyrilene | increases methylation | ISO | RGD:1354512 | 6480464 | Methapyrilene results in increased methylation of RAB8A intron | CTD | PMID:30157460 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:621144 | 6480464 | [INS1 protein co-treated with mono-2-ethylhexylphthalate] results in decreased expression of RAB8A protein | CTD | PMID:28526321 | paracetamol | decreases expression | ISO | RGD:1354512 | 6480464 | Acetaminophen results in decreased expression of RAB8A mRNA | CTD | PMID:29067470 | parathion | increases methylation | ISO | RGD:1354512 | 6480464 | Parathion results in increased methylation of RAB8A promoter | CTD | PMID:22847954 | piroxicam | increases expression | ISO | RGD:1354512 | 6480464 | Piroxicam results in increased expression of RAB8A mRNA | CTD | PMID:21858171 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of RAB8A protein | CTD | PMID:25505154 | rotenone | multiple interactions | EXP | | 6480464 | Rotenone promotes the reaction [SNCA protein mutant form binds to RAB8A protein] | CTD | PMID:15099020 | sodium arsenate | increases expression | EXP | | 6480464 | sodium arsenate results in increased expression of RAB8A mRNA | CTD | PMID:30953684 | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of RAB8A protein | CTD | PMID:27548804 | sunitinib | decreases expression | ISO | RGD:1354512 | 6480464 | Sunitinib results in decreased expression of RAB8A mRNA | CTD | PMID:31533062 | terbufos | increases methylation | ISO | RGD:1354512 | 6480464 | terbufos results in increased methylation of RAB8A promoter | CTD | PMID:22847954 | tert-butyl hydroperoxide | decreases expression | ISO | RGD:1354512 | 6480464 | tert-Butylhydroperoxide results in decreased expression of RAB8A mRNA | CTD | PMID:15336504 | thalidomide | decreases expression | EXP | | 6480464 | Thalidomide results in decreased expression of RAB8A mRNA | CTD | PMID:26006729 | trichloroethene | increases expression | ISO | RGD:621144 | 6480464 | Trichloroethylene results in increased expression of MEL mRNA | CTD | PMID:17190186 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of RAB8A mRNA | CTD | PMID:17292431 | valproic acid | increases expression | ISO | RGD:1354512 | 6480464 | Valproic Acid results in increased expression of RAB8A mRNA | CTD | PMID:23179753 | |